Tumor-infiltrating lymphocytes and hepatocellular carcinoma: pathology and clinical management-Reference-Cited by-同舟云学术

Tumor-infiltrating lymphocytes and hepatocellular carcinoma: pathology and clinical management

Published:2010-10-21 Issue:6 Volume:15 Page:552-558
ISSN:1341-9625
Container-title:International Journal of Clinical Oncology
language:en
Short-container-title:Int J Clin Oncol

Author:

Shirabe Ken,Motomura Takashi,Muto Jun,Toshima Takeo,Matono Rumi,Mano Yohei,Takeishi Kazuki,Ijichi Hideki,Harada Noboru,Uchiyama Hideaki,Yoshizumi Tomoharu,Taketomi Akinobu,Maehara Yoshihiko

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Hematology,General Medicine,Surgery

Link

http://link.springer.com/content/pdf/10.1007/s10147-010-0131-0.pdf

Reference59 articles.

1. Scherlock S (1994) Viruses and hepatocellular carcinoma. Gut 35:828–832

2. Shirabe K, Kanematsu T, Matsumata T et al (1991) Factors linked to early recurrence of small hepatocellular carcinoma after hepatectomy: univariate and multivariate analyses. Hepatology 14:802–805

3. Taketomi A, Fukuhara T, Morita K et al (2010) Improved results of a surgical resection for the recurrence of hepatocellular carcinoma after living donor liver transplantation. Ann Surg Oncol. [Epub ahead of print]

4. Shirabe K, Matsumata T, Maeda T et al (1995) A long-term surviving patient with hepatocellular carcinoma including lymphocytes infiltration: a clinicopathological study. Hepatogastroenterology 42:996–1001

5. Wada Y, Nakashima O, Kutami R et al (1998) Clinicopathological study on hepatocellular carcinoma with lymphocytic infiltration. Hepatology 27(2):407–414

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tumor-infiltrating T-Lymphocyte immunity-related immune tolerance and anti–programmed cell death protein 1/ligand of programmed cell death protein 1 therapy for advanced hepatocellular carcinoma;Oncology and Translational Medicine;2024-06-03

2. Comprehensive characterization of Fidgetin on tumor immune microenvironment evaluation and immunotherapy in human hepatocellular carcinoma;Aging;2024-02-27

3. Identification of immune cell-related prognostic genes characterized by a distinct microenvironment in hepatocellular carcinoma;World Journal of Clinical Oncology;2024-02-24

4. Characterization of lymphocyte‐rich hepatocellular carcinoma and the prognostic role of tertiary lymphoid structures;Liver International;2024-02-16

5. Clinical impact of sarcopenia in early-stage intrahepatic recurrent hepatocellular carcinoma: an association with impaired host immunity;Langenbeck's Archives of Surgery;2023-11-10